In hepatocellular carcinoma, genomic modifications were mainly detected in the KEAP1 gene [168] and in urothelial bladder carcinoma a probable link with NRF2 and thioredoxin signaling was observed [169]. This evidence concerns the gene TXN and bladder transitional cell carcinoma.